The GH/IGF-1 system in critical illness

被引：66
|
作者：
Elijah, Itoro E.
Branski, Ludwik K.
Finnerty, Celeste C.
Herndon, David N. [1 ]
机构：
[1] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2011年 / 25卷 / 05期
基金：
美国国家卫生研究院;
关键词：
trauma; burns; hypermetabolism; protein wasting; IGFBP-3; hepatic acute care response; gut atrophy; nutrition; mortality; anabolic therapy; GROWTH-FACTOR-I; HORMONE TREATMENT; GENE-TRANSFER; BACTERIAL TRANSLOCATION; CATIONIC LIPOSOMES; MESSENGER-RNA; EXPRESSION; THERAPY; PROTEINS; SERUM;
D O I：
10.1016/j.beem.2011.06.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) axis plays a pivotal role in critical illness, with a derangement leading to profound changes in metabolism. Protein wasting with skeletal muscle loss, delayed wound healing, and impaired recovery of organ systems are some of the most feared consequences. The use of human recombinant Growth Hormone (rhGH) and Insulin-like Growth Factor-1 (IGF-1) - alone and in combination - has been studied extensively in preclinical and clinical trials. This article reviews the current knowlegde and clinical practice of the use of rhGh and IGF-1 in critically ill patients, with a special focus on the trauma and burns patient population. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：759 / 767
页数：9
相关论文
共 50 条
  • [21] The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
    Darlene E. Berryman
    Camilla A. M. Glad
    Edward O. List
    Gudmundur Johannsson
    Nature Reviews Endocrinology, 2013, 9 : 346 - 356
  • [22] Correlation between GH and IGF-1 during treatment for acromegaly
    Oldfield, Edward H.
    Jane, John A., Jr.
    Thorner, Michael O.
    Pledger, Carrie L.
    Sheehan, Jason P.
    Vance, Mary Lee
    JOURNAL OF NEUROSURGERY, 2017, 126 (06) : 1959 - 1966
  • [23] Measurement of IGF-1, IGFBP-3 and free IGF-1 levels by ELISA in growth hormone (GH) deficient children before and after GH replacement
    Wacharasindhu, S
    Aroonparkmongkol, S
    Srivuthana, S
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2002, 20 (03): : 155 - 160
  • [24] Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
    Rosario, Pedro W.
    Calsolari, Maria R.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (06): : 510 - 514
  • [25] Effects of IGF-1 on the Cardiovascular System
    Obradovic, Milan
    Zafirovic, Sonja
    Soskic, Sanja
    Stanimirovic, Julijana
    Trpkovic, Andreja
    Jevremovic, Danimir
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (35) : 3715 - 3725
  • [26] Changes within the GH/IGF-I/IGFBP axis in critical illness
    Mesotten, D
    Van den Berghe, G
    CRITICAL CARE CLINICS, 2006, 22 (01) : 17 - +
  • [27] IGF-1 and GH in living-donor liver transplantation.
    Stockmann, M
    Hünerbein, D
    Nolting, S
    Gräf, KJ
    Konrad, T
    Steinmüller, T
    Neuhaus, P
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 533 - 533
  • [28] The Potential Effects of IGF-1 and GH on Patients With Chronic Heart Failure
    Perkel, David
    Naghi, Jesse
    Agarwal, Megha
    Morrissey, Ryan P.
    Phan, Anita
    Willix, Robert D., Jr.
    Schwarz, Ernst R.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (01) : 72 - 78
  • [29] Genetic and GH/IGF-1 effects on vertebral trabecular architecture.
    Donahue, LR
    Rosen, CJ
    Muller, R
    Shultz, KL
    Guido, V
    Beamer, WG
    Bouxsein, ML
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S235 - S235
  • [30] Hippocampal GH and IGF-1 expression in GH-deficient long-lived mice
    Sun, L
    Bartke, A
    GERONTOLOGIST, 2004, 44 : 19 - 19
12345